by David Kent | Nov 7, 2019
In October, I participated in a workshop hosted by Medicine by Design (MbD) in Toronto. The workshop was right up my alley – blood stem cells and clonal evolution – but I’ll spare the Signals readership the specific details.* Rather, today’s post focuses...
by Farah Qaiser | Oct 30, 2019
Earlier this month, over 8,900 individuals (including me!) headed to Houston to attend the 2019 American Society of Human Genetics’ (ASHG) Annual Meeting and learn more about cutting-edge research, science literacy and policy issues in the fields of genetics and...
by Stacey Johnson | Oct 4, 2019
One of the speakers invited to the Current Trends in Biotherapeutics Workshop, hosted by the Clinical Translation Education Group (CTEG),* was Alexandre Le Bouthillier, co-founder of Imagia. This Montreal-based company is harnessing the power of artificial...
by Stacey Johnson | Sep 6, 2019
The field of biotherapeutics – treatments produced by, or involving, living cells – is quickly evolving with the popularity and pursuit of new cell therapies. If you’re a student or young professional working in this space, you know this already. But how familiar are...
by Farah Qaiser | Aug 15, 2019
Science doesn’t usually get a lot of attention during elections, and we think that this needs to change. That’s why, on August 8th, a coalition of science groups, including Evidence For Democracy, the Toronto Science Policy Network (TSPN) and the Science & Policy...
by Stacey Johnson | Aug 14, 2019
Canadian science groups and a non-partisan organization that promotes the “transparent use of evidence in government decision-making in Canada” have come together to launch a national campaign before Canadians go to the polls this fall to elect their federal...
Comments